Clinical trials in Russia
1,241 studies list at least one site in Russia. 288 are recruiting or about to start. Per ClinicalTrials.gov, last updated 2026-09-24.
Status
- Completed
- 525
- Active, not recruiting
- 363
- Recruiting
- 244
- Terminated
- 60
- Not yet recruiting
- 27
- Enrolling by invitation
- 17
Phase
- Phase 3
- 598
- Phase 2
- 213
- Phase 1
- 71
- Phase 4
- 35
- Early Phase 1
- 1
Most studied here
Who runs them
AstraZeneca (110) · Merck Sharp & Dohme LLC (73) · Tomsk National Research Medical Center of the Russian Academy of Sciences (60) · Hoffmann-La Roche (60) · Novartis Pharmaceuticals (56) · Janssen Research & Development, LLC (39) · Sanofi (36) · I.M. Sechenov First Moscow State Medical University (33)
Studies
Recruiting first, then most recently updated. Showing 50 of 1,241 — search for more.
- A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative ColitisRecruitingNCT05076175Phase 2/3
- Evaluation of the Effectiveness of Micronized Purified Flavonoid Fraction (MPFF) in Patients With Haemorrhoids Undergoing Minimally Invasive Surgical InterventionsRecruitingNCT07647172
- A Repeated Dose-finding Study of Sarilumab in Children and Adolescents With Systemic Juvenile Idiopathic Arthritis (SKYPS)RecruitingNCT02991469Phase 2
- Pan Tumor Rollover StudyRecruitingNCT03899155Phase 2
- Extension Study for Participants in Studies That Include Belzutifan (MK-6482-043/LITESPARK-043)RecruitingNCT07405164Phase 3
- A Study of Baricitinib in Participants From 1 Year to Less Than 18 Years Old With Juvenile Idiopathic ArthritisRecruitingNCT03773965Phase 3
- Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)RecruitingNCT04924075Phase 2
- Study to Determine the Dose and Safety of Asciminib in Pediatric Patients With Chronic Myeloid LeukemiaRecruitingNCT04925479Phase 1/2
- BI-1808 as a Single Agent and With Pembrolizumab (KEYTRUDA® ) in Treatment of Advanced Malignancies(Keynote-D20)RecruitingNCT04752826Phase 1/2
- Long-term Safety and Tolerability of Inclisiran in Participants With HeFH or HoFH Who Have Completed the Pediatric ORION-16, ORION-13, ORION-20, or ORION-19 StudiesRecruitingNCT05682378Phase 3
- Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)RecruitingNCT03486873Phase 3
- Low INR to Minimize Bleeding With Mechanical Valves TrialRecruitingNCT03636295Phase 3
- Non-Interventional Study of Ferretab® Comp. (Ferrous Fumarate + Folic Acid Prolonged-Release Capsules) Effects in Adult Patients With Iron Deficiency Anemia and Cardiovascular DiseaseNot yet recruitingNCT07753031
- Alloplastic Total Temporomandibular Joint (TMJ) Replacement RegistryRecruitingNCT03991728
- ReAl-woRld Evaluation of tEzepelumab for Chronic rhinoSinusitis With Nasal Polyps in RussiaRecruitingNCT07399665
- Radical Prostatectomy Without Prior BiopsyNot yet recruitingNCT07819760Not applicable
- Study of Olverembatinib (HQP1351) in Patients With CML-CPRecruitingNCT06423911Phase 3
- Neurovascular Product Surveillance RegistryRecruitingNCT02988128
- TReatment Approaches and bIomarkers preValence in bladdEr Cancer in RuSsian FederationRecruitingNCT07038928
- Vercise™ DBS Dystonia Prospective StudyRecruitingNCT02686125
- Epidemiological Study of Treatment Approaches in AChR-Antibody Positive Generalized Myasthenia Gravis in RussiaRecruitingNCT07247279
- Analysis of the Etiopathogenesis of Postoperative Complications in Orthopedic Patients Using Knee and Hip Arthroplasty as an ExampleRecruitingNCT07813832
- A Prospective, Single-center, Non-randomized, Interventional Study on the Effectiveness and Safety of Combined Immunotargeted Therapy in Patients With Metastatic Non-small Cell Cancer With a RET Gene TranslocationRecruitingNCT07809256Phase 3
- An Observational Study of Molecular profIling of Advanced and aggRessive ENdometrial Cancer and 1-st Line Treatment Approaches in Russian FederationRecruitingNCT07041606
- An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)RecruitingNCT07517263Phase 3
- A Phase 3 Study for the Efficacy and Safety of Radotinib in CP-CML Patients With Failure or Intolerance to Previous TKIsRecruitingNCT03459534Phase 3
- A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Obinutuzumab in Adolescents With Active Class III or IV Lupus Nephritis and the Safety and PK of Obinutuzumab in Pediatric ParticipantsRecruitingNCT05039619Phase 2
- Study of Patient With Frequent Exacerbations in MoscowRecruitingNCT07307781
- Sino-Russian Comparison of Outcomes After Proximal Gastrectomy With Double-Tract ReconstructionNot yet recruitingNCT07800819
- A Rollover Study for Participants Previously Enrolled in a Genentech and/or F. Hoffman-La Roche Sponsored StudyRecruitingNCT05862285Phase 3
- A Phase 1b Study of Lonitoclax + Azacitidine in Acute Myeloid Leukemia PatientsRecruitingNCT07303660Phase 1
- A Study Providing Treatment Access in Participants With Pulmonary Hypertension Completing a Parent Study and Having no Other OptionRecruitingNCT05179876Phase 3
- Clinical and demOgRaphic Features of Patients With Uncontrolled Severe Asthma in Russia (CORSAR)RecruitingNCT06472310
- Sentinel Node Identification Using Gamma and Near-Infrared Imaging in TesticulAr MaLignanciesRecruitingNCT07777887
- Molecular Imaging of EpCam Expression in Breast Cancer Using [99mTc]Tc-DARPinEc1-G3CEnrolling by invitationNCT07784660Phase 1
- Efferon CT Hemoadsorption for Cardiogenic Shock in Acute Myocardial InfarctionRecruitingNCT06955936Not applicable
- Efferon LPS Hemoadsorption in Cardiac Surgery PatientsRecruitingNCT07532174Not applicable
- Clinical and Demographic Characteristics of Adult p Atients With NEurofibromatosis in RUSsiaRecruitingNCT07088991
- A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular LymphomaRecruitingNCT03460977Phase 1
- Prospective Global Registry for the Study of Chronic Total Occlusion InterventionRecruitingNCT02061436
- Secukinumab Open Label Roll-over Extension ProtocolRecruitingNCT04638647Phase 4
- Aggressive Disease Treatment Patterns and CtDNA HRR evaluatiON in High-volume metastatiC hORmone-sensitive Prostate Cancer in Russian FeDerationRecruitingNCT07052578
- D2 vs D3 Lymph Node Dissection for Left Colon CancerRecruitingNCT04364373Not applicable
- CompariSon Between the EuroPeAn and Japanese pathologiCal InvEstigation for Colon Cancer (SPACE)RecruitingNCT06119867Phase 3
- Ketamine Infusion as a Method of Cerebral Protection in ChildrenRecruitingNCT06525584Not applicable
- An Open-label Study to Assess Safety and Efficacy of SZC in Paediatric Patients With HyperkalaemiaRecruitingNCT03813407Phase 3
- Sarcopenia in Acute Ischemic StrokeRecruitingNCT07764172
- Posaconazole (MK-5592) Intravenous and Oral in Children (<2 Years) With Invasive Fungal Infection (MK-5592-127)RecruitingNCT04665037Phase 2
- Roll Over StudY for Patients Who Have Completed a Previous Oncology Study With DurvalumabEnrolling by invitationNCT05303532Phase 3
- Pneumonia After Cardiovascular Surgery With Artificial IntelligenceRecruitingNCT07745491